Investigation Overview
April 6, 2015 (Shareholders Foundation) - An investigation on behalf of investors, who currently hold shares of Hyperion Therapeutics Inc (NASDAQ:HPTX), was announced concerning whether the takeover of Hyperion Therapeutics Inc by Horizon Pharma plc for $46.00 per share is unfair to NASDAQ:HPTX stockholders. The investigation by a law firm concerns whether certain officers and direct...
You must register (for free) or login to view the entire investigation.